Form 4 for LH Labcorp
Accepted 2022-08-03 00:00:00 ET · period of report 2022-08-01 · accession 0001127602-22-020320 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-03 | 2022-08-01 | LH | Wilkinson Peter J | SVP, CAO | S - Sale+OE | $258.40 | -2,576 | 1,897 | -58% | -$665.6K |
| DM | 2022-08-03 | 2022-08-01 | LH | Wilkinson Peter J | SVP, CAO | M - OptEx | $146.59 | +817 | 2,654 | +44% | +$119.8K |
| D | 2022-08-03 | 2022-08-01 | LH | Wilkinson Peter J | SVP, CAO | F - Tax | $257.94 | -23 | 1,914 | -1% | -$5,933 |
| DM | 2022-08-03 | 2022-08-01 | LH | Wilkinson Peter J | SVP, CAO | M - OptEx | $0.00 | -817 | 764 | -52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-01 | S | D | 10 | $258.71 | 1,887.22 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-01 | M | A | 50 | — | 1,937.22 | D | — | — | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. |
| 3 | Common | Common Stock | 2022-08-01 | F | D | 23 | $257.94 | 1,914.22 | D | — | — | |
| 4 | Common | Common Stock | 2022-08-01 | M | A | 767 | $146.59 | 2,654.22 | D | — | — | |
| 5 | Common | Common Stock | 2022-08-01 | S | D | 1,809 | $258.31 | 1,887.22 | D | — | — | |
| 6 | Common | Common Stock | 2022-08-01 | S | D | 757 | $258.60 | 1,897.22 | D | — | — | |
| 7 | Derivative | Non-qualified Stock Options | 2022-08-01 | M | D | 767 | $0.00 | 0 | D | $146.59 · 2020-02-12 to 2029-02-11 | 767 Common Stock | (F3) Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. (F4) The option vested in three equal annual installments beginning on the date reflected in this column. |
| 8 | Derivative | Restricted Stock Unit | 2022-08-01 | M | D | 50 | $0.00 | 764 | D | — · — to — | 50 Common Stock | (F6) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. (F5) The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on August 1, 2021. |